US Drug Recall Register
Class II · Moderate risk Terminated Initiated Feb 5, 2024 (3 years ago)

Voriconazole for Oral Suspension

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Labeling: Incorrect or Missing Package Insert

What was recalled

Voriconazole for Oral Suspension, 40mg/mL, Orange-Flavored, 49g/75mL when reconstituted. Mixing Directions: Tap the bottle to release the powder. Add 50mL of water to the bottle and shake vigorously for 1 minute. Manufactured by: Novel Laboratories, Inc. Somerset, NJ 08873. Manufactured for: Lupin Pharmaceuticals Inc. Baltimore, MD 21202. NDC: 43386-038-60.

Recalling firm
Lupin Pharmaceuticals Inc.
Origin
MD, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0337-2024

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Orange recalls

See all
Class II · Moderate risk Ongoing

BD ChloraPrep Hi-Lite Orange

Reason Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers outside of the intended distribution channel

CareFusion 213, LLC NDC 54365-400-38 D-0648-2026
Class II · Moderate risk Ongoing

BD ChloraPrep Hi-Lite Orange

Reason Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers outside of the intended distribution channel

CareFusion 213, LLC NDC 54365-400-33 D-0647-2026
Class II · Moderate risk Ongoing

BD ChloraPrep Hi-Lite Orange

Reason Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers outside of the intended distribution channel

CareFusion 213, LLC NDC 54365-400-35 D-0643-2026
Class II · Moderate risk Ongoing

Dynarex

Reason CGMP Deviations

Acme United Corporation NDC 67777-245-04 D-0376-2026
Class II · Moderate risk Ongoing

Dynarex

Reason CGMP Deviations

Acme United Corporation NDC 67777-245-01 D-0375-2026